As the AIMS-2-TRIALS project draws to a close, data collected in a unique longitudinal study is becoming available to researchers, via a managed access plan.
Source: Read the full original article, First release of data from AIMS-2-TRIALS to the autism research community, on the website of the Innovative Health Initiative (IHI)